Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-20-021799
Filing Date
2020-10-28
Accepted
2020-10-28 13:51:51
Documents
2
Period of Report
2020-10-28
Effectiveness Date
2020-10-28

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A inbp20201026_def14a.htm DEF 14A 412227
2 ibp_logo.jpg GRAPHIC 12671
  Complete submission text file 0001437749-20-021799.txt   430595
Mailing Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Filer) CIK: 0001016504 (see all company filings)

EIN.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-31668 | Film No.: 201267613
SIC: 2834 Pharmaceutical Preparations